Issued Patents 2023
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11833194 | Peptides and combination of peptides for use in immunotherapy against various cancers | Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-12-05 |
| 11826410 | Peptides and combination of peptides for use in immunotherapy against various cancers | Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-11-28 |
| 11826409 | Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more | 2023-11-28 |
| 11793866 | Peptides and T cells for use in immunotherapeutic treatment of various cancers | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-10-24 |
| 11786584 | Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more | 2023-10-17 |
| 11786583 | Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers | Toni Weinschenk, Jens Fritsche, Phillip Mueller, Anita Wiebe, Sarah Kutscher | 2023-10-17 |
| 11779638 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Jens Fritsche, Phillip Mueller, Anita Wiebe, Sarah Kutscher | 2023-10-10 |
| 11744882 | Peptides and T cells for use in immunotherapeutic treatment of various cancers | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-09-05 |
| 11702460 | Peptides and combination of peptides for use in immunotherapy against various tumors | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh, Lea Stevermann | 2023-07-18 |
| 11679147 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Jens Fritsche, Phillip Mueller, Anita Wiebe, Sarah Kutscher | 2023-06-20 |
| 11673917 | Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers | Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-06-13 |
| 11672848 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Jens Fritsche, Phillip Mueller, Anita Wiebe, Sarah Kutscher | 2023-06-13 |
| 11608370 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-03-21 |
| 11597752 | Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers | Oliver Schoor, Toni Weinschenk, Anita Wiebe, Jens Fritsche, Harpreet Singh | 2023-03-07 |
| 11576954 | Method for treating non-small lung cancer with a population of activated cells | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-02-14 |
| 11576956 | Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers | Toni Weinschenk, Jens Fritsche, Phillip Mueller, Anita Wiebe, Sarah Kutscher | 2023-02-14 |
| 11559573 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Jens Fritsche, Phillip Mueller, Anita Wiebe, Sarah Kutscher | 2023-01-24 |
| 11559572 | Peptides and T cells for use in immunotherapeutic treatment of various cancers | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-01-24 |
| 11547750 | Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-01-10 |
| 11541107 | Peptides and T cells for use in immunotherapeutic treatment of various cancers | Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh | 2023-01-03 |